-
'Smart warheads' of cancer: Experts' excitement for treatment approach grows
Cancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody to deliver targeted doses of chemo to cancer cells, with fewer side effects. -
The important patient aspect some cancer centers forget about
There's an aspect of patient life that many hospitals forget when creating a cancer treatment plan — fertility. -
UAMS creates distinguished chair post in oncologist's honor
Little Rock-based The University of Arkansas for Medical Sciences created the Omar T. Atiq, MD, MACP, Distinguished Chair in Physician Leadership and appointed Dr. Atiq as the inaugural chair. -
No new cervical cancer cases found in large HPV vaccine study
For the first time, a large study of young women had no new cases of cervical cancer after receiving the human papillomavirus vaccine. -
Fox Chase documents 1st case of rare cancer in the rectum
Philadelphia-based Fox Chase Cancer Center has documented the first case of myxoid leiomyosarcoma in the rectum. -
The link between proximity to cancer centers and stage of disease: New findings
Patients who live farther away from a designated comprehensive cancer center may be more likely to receive a late-stage diagnosis, according to an analysis of medical records from researchers at Baltimore-based John Hopkins Medicine. -
The real cost of cancer: 49% of patients carry $5K+ in medical debt
Rising drug prices and inflationary effects have escalated the price tag of a cancer diagnosis for both hospitals and patients. Now, 47% of cancer patients accumulate debt as a result of their medical needs, The Wall Street Journal reported May 28. -
FDA updates cancer trial eligibility guidelines
In April, the FDA published three new draft guidelines for cancer clinical trial eligibility criteria that aim to improve the representation of participants. -
AI + navigation = faster cancer care at Northwell
New Hyde Park, N.Y.-based Northwell Health has reduced the number of days that pancreatic cancer patients wait until they receive a biopsy, oncology visit and treatment initiation with its new navigation and artificial intelligence program. -
FDA considers 2nd blood test for colon cancer — but advisers note concerns
FDA advisers have recommended the approval of Guardant Health's blood test to detect colon or rectal cancers — but it also raised some concerns, NBC News reported May 23. -
Internationally trained women oncologists face more discrimination: 4 notes
A recent study from the University of Miami's Sylvester Comprehensive Cancer Center found that women oncologists who graduated from international medical schools report experiencing roughly 10 times as much discrimination as their male counterparts. -
UCSF launches 1st long-term study for cancer in Asian Americans
UC San Francisco is launching the first long-term study of cancer among Asian Americans. -
U of Kentucky's Markey Cancer Center inks international partnership
The Markey Cancer Center in Lexington, Ky., part of the University of Kentucky, has inked a new partnership with Ukraine's Kyiv Regional Oncology Dispensary, according to a May 22 news release. -
The top contributors to oncologist depression
Oncologist depression rates remained steady compared to 2023, hovering around 20%, according to a Medscape report. -
Oncologists should 'revisit' end-of-life care goals: Yale, MD Anderson study
Administering more treatments to advanced, end-of-life cancer patients did not increase their length of survival, according to a joint study from researchers at Yale Cancer Center in New Haven, Conn., and the University of Texas MD Anderson Cancer Center in Houston. -
3 hospitals piloting blood tests to detect cancer
More hospitals and systems are testing the effectiveness of blood tests to detect cancer. -
Allina Health launches cancer mobile app
Minneapolis-based Allina Health launched a cancer mobile app that provides breast cancer patients with information to navigate their diagnosis and treatment. -
Blood Centers of America, biotech partner on CAR-T manufacturing
Blood Centers of America will partner with Galapagos to help manufacture the Belgian biotech firm's CAR-T cell therapies, the companies said May 15. -
7 cancer disparities to watch for in 2024
In 2024, more than 2 million new cancer cases are projected to be diagnosed, and more than 611,700 deaths from cancer are expected, a May American Association of Cancer Research report found. -
FDA approves self-collection HPV screening test
The FDA approved a human papillomavirus self-collection test that can be gathered in private rooms in primary care offices, urgent care clinics and pharmacies, The Washington Post reported May 15.
Page 12 of 50